Global Coalition for Adaptive Research Inc.

“Draft of form 990 is prepared by outside cpa firm. The draft is reviewed by the directors, ceo, and coo before it is filed.”

“Each director and officer is required to submit an updated conflict of interest statement on an annual basis. To the extent that relationships are identified via these statements and other information, the individual's constitent record in the company database is updated to include this information, facilitating periodic queries, as necessary. Any board member with a conflict must identify the conflict at any board meeting where the conflict is relevant. The member cannot be present at any part of the meeting where the relevant topic is discussed or voted on. The member cannot be counted for a quorum.”

“The board of directors is responsible for the review and approval of top-level executive management compensation annually. Independent professional experts are called upon for higher-level positions and assist in establishing executive salaries in the competitive marketplace. Salaries in both for profit and not for profit organizations are evaluated in order to attract the most talented personnel. Information is gathered, analyzed and discussed with the intent on ensuring that the executive compensation program falls within a reasonable range of competitive practices for comparable positions among similarly situated organizations. The review includes incentive plans and all fringe benefits as well as base salary arrangements.”

“Gcar has a formal policy for public disclosure and inspection of documents. The policy is available to all upon request.”

“1) to provide grants, funds, aid and assistance to scientific and medical institutes, scientists and physicians engaged in medical and scientific research as to the causes of, prevention of, early diagnosis of, and treatment of cancers of all types; 2) to promote and support the use of cancer-specific platform trials of new drugs and other treatments of cancer so that multiple treatment modalities may be tested and evaluated simultaneously; ongoing clinical trials may be continuously updated to incorporate the latest clinical trial research results; and the most effective treatment protocols for various types of cancer may be developed and approved sooner; 3) to promote and support financially and otherwise, public education as to the use of cancer-specific platform trials that result in protocols that may lead to earlier diagnosis and treatment of cancers of all types; 4) to underwrite, sponsor, and support academic and scholarly studies, symposia, curricula development, research, seminars, and presentation as to the topics set forth above in governmental institutions, in the media and in schools, colleges, universities and other educational institutions throughout the united states and abroad; 5) to encourage state and federal government agencies to provide adequate funding to promote the use of cancer-specific platform trials that can lead to more efficacious treatments of cancer and the ability of cancer patients to avail themselves of such treatments sooner than previously possible via standard clinical trial protocols; 6) to accomplish the above purposes by all reasonable an practical means, including the publication and dissemination of information in all forms and through all media, to the public in the united states and in foreign states; and 7) to engage in any lawful acts and enter into all lawful agreements that may be necessary, useful, suitable or proper to accomplish the charitable purposes of the corporation, provided the same is permitted under section 501(c)(3) of the code.”

“Independent consultants: program service expenses 1,983,249. Management and general expenses 108,223. Fundraising expenses 0. Total expenses 2,091,472.”